1. Home
  2. ORKT vs RNXT Comparison

ORKT vs RNXT Comparison

Compare ORKT & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORKT
  • RNXT
  • Stock Information
  • Founded
  • ORKT 2003
  • RNXT 2012
  • Country
  • ORKT Singapore
  • RNXT United States
  • Employees
  • ORKT N/A
  • RNXT N/A
  • Industry
  • ORKT
  • RNXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORKT
  • RNXT Health Care
  • Exchange
  • ORKT NYSE
  • RNXT Nasdaq
  • Market Cap
  • ORKT 34.7M
  • RNXT 31.6M
  • IPO Year
  • ORKT 2024
  • RNXT 2021
  • Fundamental
  • Price
  • ORKT $1.23
  • RNXT $1.04
  • Analyst Decision
  • ORKT Strong Buy
  • RNXT Strong Buy
  • Analyst Count
  • ORKT 1
  • RNXT 1
  • Target Price
  • ORKT $5.00
  • RNXT $9.00
  • AVG Volume (30 Days)
  • ORKT 6.9M
  • RNXT 226.9K
  • Earning Date
  • ORKT 10-16-2024
  • RNXT 03-31-2025
  • Dividend Yield
  • ORKT N/A
  • RNXT N/A
  • EPS Growth
  • ORKT N/A
  • RNXT N/A
  • EPS
  • ORKT N/A
  • RNXT N/A
  • Revenue
  • ORKT $3,904,592.00
  • RNXT N/A
  • Revenue This Year
  • ORKT N/A
  • RNXT N/A
  • Revenue Next Year
  • ORKT N/A
  • RNXT N/A
  • P/E Ratio
  • ORKT N/A
  • RNXT N/A
  • Revenue Growth
  • ORKT N/A
  • RNXT N/A
  • 52 Week Low
  • ORKT $0.62
  • RNXT $0.77
  • 52 Week High
  • ORKT $8.00
  • RNXT $1.86
  • Technical
  • Relative Strength Index (RSI)
  • ORKT N/A
  • RNXT 32.70
  • Support Level
  • ORKT N/A
  • RNXT $1.00
  • Resistance Level
  • ORKT N/A
  • RNXT $1.18
  • Average True Range (ATR)
  • ORKT 0.00
  • RNXT 0.10
  • MACD
  • ORKT 0.00
  • RNXT -0.04
  • Stochastic Oscillator
  • ORKT 0.00
  • RNXT 8.00

About ORKT ORANGEKLOUD TECHNOLOGY INC

Orangekloud Technology Inc is a company that operates through its subsidiaries provide IT consultancy services and distribution of related products and services. The Company also offers ERPs predominately in Singapore. It derives revenue from platform subscriptions, license and products and professional services.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: